Abstract
Continuous monitoring of neovascular growth in vivo is required for the development and evaluation of drugs acting as suppressors or stimulators of angiogenesis. The cornea assay consists of the placement of an angiogenesis stimulus (tumor tissue, cell suspension, growth factor) into a micropocket produced in the cornea thickness to evoke vascular outgrowth from the peripherally located limbal vasculature. Neovascular development and progression can be modified by the presence of locally released or applied inhibitory factors or by systemically given antiangiogenic drugs. This assay has the advantage over other in vivo assays of measuring new blood vessels only since the cornea is initially avascular. The experimental details of the avascular cornea assay and its advantages and disadvantages in different species are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jain, R. K., Schlenger, K., Hockel, M., Yuan, F. (1997) Quantitative angiogenesis assays: progress and problems. Nat Med 3, 1203–1208.
Gimbrone, M., Jr., Cotran, R., Leapman, S. B., Folkman, J. (1974) Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 52, 413–427.
Langer, R., Folkman. J. (1976) Polymers for the sustained release of proteins and other macromolecules. Nature 363, 797–800.
Ziche, M., Morbidelli, L., Choudhuri, R., et al. (1997) Nitric oxide-synthase lies downstream of vascular endothelial growth factor but not basic fibroblast growth factor induced angiogenesis. J Clin Invest 99, 2625–2634.
Marconcini, L., Marchio, S., Morbidelli, L., et al. (1999) c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci U S A 96(17), 9671–9676.
Cervenak, L., Morbidelli, L., Donati, D., et al. (2000) Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood 96, 2568–2573.
Gallo, O., Masini, E., Morbidelli, L., et al. (1998) Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90, 587–596.
Ziche, M., Morbidelli, L., Masini, E., et al. (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94, 2036–2044.
Muthukkaruppan, V., Auerbach, R. (1979) Angiogenesis in the mouse cornea. Science 206, 1416–1418.
Chen, C., Parangi, S., Tolentino, M.T., Folkman, J. (1995) A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res 55, 4230—4233.
Voest, E. E., Kenyon, B. M., O’Really, M. S., Truitt, G., D’Amato, R. J., Folkman, J. (1995) Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87, 581—586.
Polverini, P. J., Leibovich, S. J. (1984) Induction of neovascularization in vivo and endothelial cell proliferation in vitro by tumor associated macrophages. Lab Invest 51, 635–642.
Ziche, M., Jones, J., Gullino, P. M. (1982) Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst 69, 475–482.
Taraboletti, G., Morbidelli, L., Donnini, S., et al. (2000) The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinases and TIMP-2 in endothelial cells. FASEB J 14, 1674–1676.
Parenti, A., Morbidelli, L., Ledda, F., Granger, H. J., Ziche, M. (2001) The bradykinin/B1 receptor promotes angiogenesis by upregulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB J 15(8), 1487–1489.
Lasagna, N., Fantappiè, O., Solazzo, M., et al. (2006) Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. Cancer Res 66(5), 2673–2682.
Woolard, J., Wang, W. Y., Bevan, H. S., et al. (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64(21), 7822–7835.
Morbidelli, L., Donnini, S., Chillemi, F., Giochetti, A., Ziche, M. (2003) Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. Clin Cancer Res 9(14), 5358–5369.
Bagli, E., Stefaniotou, M., Morbidelli, L., et al. (2004) Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity. Cancer Res 64(21), 7936–7946.
Donnini, S., Finetti, F., Lusini, L., et al. (2006) Divergent effects of quercetin conjugates on angiogenesis. Br J Nutr 95(5), 1016–1023.
Ziche, M., Alessandri, G., Gullino, P. M. (1989) Gangliosides promote the angiogenic response. Lab Invest 61, 629–634.
Cantara, S., Donnini, S., Morbidelli, L., et al. (2004) Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2. FASEB J 18(15), 1943–1945.
Federman, J. L., Brown, G. C., Felberg, N. T., Felton, S. M. (1980) Experimental ocular angiogenesis. Am J Ophthalmol 89(2), 231–237.
Presta, M., Rusnati, M., Belleri, M., Morbidelli, L., Ziche, M., Ribatti, D. (1999) Purine analog 6-methylmercaptopurine ribose inhibits early and late phases of the angiogenesis process. Cancer Res 59(10), 2417–2424.
Ziche, M., Donnini, S., Morbidelli, L., Parenti, A., Gasparini, G., Ledda, F. (1998) Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants Br J Cancer 77(7), 1123–1129.
Acknowledgements
We would like to thank Dr. Raffaella Solito for technical assistance. The work was supported by the Italian Ministry of University (MIUR), the Italian Association for Cancer Research (AIRC), and the University of Siena.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Ziche, M., Morbidelli, L. (2009). The Corneal Pocket Assay. In: Murray, C., Martin, S. (eds) Angiogenesis Protocols. Methods in Molecular Biology, vol 467. Humana Press. https://doi.org/10.1007/978-1-59745-241-0_20
Download citation
DOI: https://doi.org/10.1007/978-1-59745-241-0_20
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-907-9
Online ISBN: 978-1-59745-241-0
eBook Packages: Springer Protocols